Huiyu Pharmaceutical(SH:688553) Shang Hai Zheng Quan Bao·2025-09-26 18:35Core Viewpoint - The company plans to provide a guarantee of up to 100 million RMB for its wholly-owned subsidiary, Sichuan Huiyu Pharmaceutical Co., Ltd., to support its liquidity needs for bank loans [1][5]. Group 1: Guarantee Details - The guarantee amount will not exceed 100 million RMB, and the specific amount will be determined based on the agreement with the bank [1]. - The guarantee is intended to meet the operational development needs of the subsidiary, ensuring its stable business growth [5]. - The guarantee is within the company's board approval authority and does not require shareholder meeting approval, as it does not exceed 30% of the company's latest audited total assets [2]. Group 2: Internal Decision Process - The company's board of directors held a meeting on September 26, 2025, where the proposal for the guarantee was approved unanimously [10][12]. - The board believes that the guarantee aligns with the company's operational needs and will enhance overall financing efficiency [12]. Group 3: Financial Implications - As of the announcement date, the company has provided a total of 12.02 million RMB in guarantees to its subsidiaries, which is 0.302% of the latest audited net assets [6]. - With the new guarantee, the total amount of guarantees provided to subsidiaries will rise to 11.202 million RMB, representing 2.815% of the latest audited net assets [6]. Group 4: Risk Management - The company asserts that the guarantee risk is manageable and does not pose a threat to the interests of the company or its shareholders, particularly minority shareholders [5][12]. - There are currently no overdue guarantees or litigation-related guarantees involving the company or its subsidiaries [7].